The use of guinea pigs in tests for immunogenic capacity of poliomyelitis virus preparations.
作者信息
GARD S, WESSLEN T, FAGRAEUS A, SVEDMYR A, OLIN G
出版信息
Arch Gesamte Virusforsch. 1956;6(5):401-11. doi: 10.1007/BF01245926.
PMID:13340710
Abstract
摘要
相似文献
1
The use of guinea pigs in tests for immunogenic capacity of poliomyelitis virus preparations.
Arch Gesamte Virusforsch. 1956;6(5):401-11. doi: 10.1007/BF01245926.
2
Studies on poliomyelitis virus. II. The immunogenic potency of live and inactivated virus in guinea-pigs.
J Hyg (Lond). 1958 Jun;56(2):260-5. doi: 10.1017/s0022172400037736.
3
Experiences with the guinea pig test for immunogenic capacity of poliomyelitis virus and virus preparations.
Arch Gesamte Virusforsch. 1957;7(4):369-77. doi: 10.1007/BF01240744.
4
[HETEROLOGOUS ANTIBODY FORMATION AFTER IMMUNIZATION WITH POLIOMYELITIS VIRUSES].
Klin Wochenschr. 1964 Dec 1;42:1192-5. doi: 10.1007/BF01533625.
5
Evaluation of the immunogenic properties of inactivated poliomyelitis vaccine by single vaccination of small laboratory animals (guinea pigs, chickens and white rats).
J Hyg Epidemiol Microbiol Immunol. 1961;5:320-9.
6
7
Complement-fixing antigens of living and inactivated poliovirus. II. Complement-fixing activity of poliomyelitis vaccine and its relation to immunogenic potency.
Am J Public Health Nations Health. 1959 Jan;49(1):53-61. doi: 10.2105/ajph.49.1.53.
8
Use of white rats for the measurement of immunogenic potency of inactived poliomyelitis vaccine.
Bull World Health Organ. 1960;22(3-4):291-3.
9
Studies of the accuracy of the guinea pig test for estimating antigenicity of poliomyelitis virus preparations.
Arch Gesamte Virusforsch. 1958;8(1):16-22. doi: 10.1007/BF01242309.
10
引用本文的文献
1
2
INTERNATIONAL STANDARDS FOR ANTI-POLIOVIRUS SERA TYPES 1, 2 AND 3.
Bull World Health Organ. 1963;29(6):711-20.
3
[Control of the activity of antipoliomyelitis vaccine].
Antonie Van Leeuwenhoek. 1961;27:287-98. doi: 10.1007/BF02538458.
4
Properties of foot-and-mouth disease virus in tissue culture. I. Changes in plaque morphology and antigenicity following passage in tissue culture.
Arch Gesamte Virusforsch. 1959;9:411-27. doi: 10.1007/BF01248831.
5
[Determination of the antigenic value of poliomyelitis vaccine].
Bull World Health Organ. 1960;22(3-4):295-305.
6
Potency of poliomyelitis vaccines estimated by an antibody combining test.
J Bacteriol. 1960 Jul;80(1):111-8. doi: 10.1128/jb.80.1.111-118.1960.
7
Neutralizing-antibody-combining (NAC) test for measuring antigenic potency of poliomyelitis vaccine.
Bull World Health Organ. 1959;20(6):1075-98.
8
Zone electrophoresis of poliovirus partially inactivated by formaldehyde.
J Hyg (Lond). 1960 Dec;58(4):419-25. doi: 10.1017/s0022172400038560.
9
[Results of an experimental vaccination against poliomyelitis].
Arch Gesamte Virusforsch. 1959;9(1):11-24. doi: 10.1007/BF01240999.
10
Studies on poliomyelitis virus. III. The use of ultra-violet light as an additional means of inactivation of formalinized vaccine.
J Hyg (Lond). 1958 Jun;56(2):266-70. doi: 10.1017/s0022172400037748.
本文引用的文献
1
The significance of protection tests with the serum of man and other animals against the Lansing strain of poliomyelitis virus.
J Immunol. 1947 Nov;57(3):285-99.
2
A POTENT ANTIPOLIOMYELITIC HORSE SERUM CONCENTRATE AND ITS EXPERIMENTAL USE IN INFECTED MONKEYS.
J Exp Med. 1931 Mar 31;53(4):553-66. doi: 10.1084/jem.53.4.553.
3
4
Vaccination against paralytic poliomyelitis performance and prospects.
Am J Public Health Nations Health. 1955 May;45(5 Pt 1):575-96. doi: 10.2105/ajph.45.5_pt_1.575.
5
[Prevention of poliomyelitis].
Nord Med. 1954 Dec 2;52(49):1689-93.
6
Studies on production of antipoliomyelitis serum in rabbits.
Proc Soc Exp Biol Med. 1954 Oct;87(1):111-4. doi: 10.3181/00379727-87-21303.
7
Detoxification of diphtheria toxin with formaldehyde mixed with an amino-acid.
Nature. 1954 Aug 28;174(4426):405-6. doi: 10.1038/174405a0.
Zotero 插件